IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel

Hagai Levine; Zongshuan Duan; Yael Bar-Zeev; Lorien C. Abroms; Amal Khayat; Sararat Tosakoon; Katelyn F. Romm; Yan Wang; Carla J. Berg

doi:10.3390/ijerph20043141

IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel

Hagai Levine, Zongshuan Duan, Yael Bar-Zeev, Lorien C. Abroms, Amal Khayat, Sararat Tosakoon, Katelyn F. Romm, Yan Wang, Carla J. Berg^*

^*Corresponding author for this work

Department of Social Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Heated tobacco products (HTPs) have expanded globally. IQOS, a global HTP leader, was launched in Israel in 2016 and the US in 2019. To inform tobacco control efforts, it is critical to understand who is likely to use HTPs in different countries with distinct regulatory and marketing contexts. Thus, we conducted a cross-sectional survey among adult (ages 18–45) online panelists in the US (n = 1128) and Israel (n = 1094), oversampling tobacco users, in the fall of 2021, and used multivariable regression to identify correlates of (1) ever using IQOS; (2) past-month vs. former among ever users; and (3) interest in trying IQOS among never users. Among US adults, correlates of ever use included being Asian (aOR = 3.30) or Hispanic (aOR = 2.83) vs. White, and past-month use of cigarettes (aOR = 3.32), e-cigarettes (aOR = 2.67), and other tobacco (aOR = 3.34); in Israel, correlates included being younger (aOR = 0.97), male (aOR = 1.64), and cigarette (aOR = 4.01), e-cigarette (aOR = 1.92) and other tobacco use (aOR = 1.63). Among never users, correlates of greater interest included cigarette and e-cigarette use in the US (β = 0.57, β = 0.90) and Israel (β = 0.88, β = 0.92). IQOS use prevalence was low (US: 3.0%; Israel: 16.2%) but represented in vulnerable subpopulations (younger adults, racial/ethnic minorities).

Original language	American English
Article number	3141
Journal	International Journal of Environmental Research and Public Health
Volume	20
Issue number	4
DOIs	https://doi.org/10.3390/ijerph20043141
State	Published - Feb 2023

Bibliographical note

Funding Information:
This research was funded by the US National Cancer Institute (R01CA239178-01A1, MPIs: Berg, Levine). Berg is also supported by other US National Institutes of Health funding, including the National Cancer Institute (R01CA215155-01A1; PI: Berg; R21CA261884-01A1, MPIs: Berg, Arem), the Fogarty International Center (R01TW010664-01, MPIs: Berg, Kegler), the National Institute of Environmental Health Sciences/Fogarty (D43ES030927-01, MPIs: Berg, Caudle, Sturua), and the National Institute on Drug Abuse (R01DA054751-01A1, MPIs: Berg, Cavazos-Rehg). Romm is supported by the National Institute on Drug Abuse (R25DA054015, MPIs: Obasi, Reitzel), the Oklahoma Tobacco Settlement Endowment Trust (TSET) contract #R22-03, and the National Cancer Institute grant awarded to the Stephenson Cancer Center (P30CA225520).

Publisher Copyright:
© 2023 by the authors.

Keywords

alternative tobacco products
global health
heated tobacco products
non-cigarette tobacco products
tobacco control
tobacco use

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/ijerph20043141

Cite this

@article{fd54a35d06f9456cbf29ad1c7a97bd33,

title = "IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel",

abstract = "Heated tobacco products (HTPs) have expanded globally. IQOS, a global HTP leader, was launched in Israel in 2016 and the US in 2019. To inform tobacco control efforts, it is critical to understand who is likely to use HTPs in different countries with distinct regulatory and marketing contexts. Thus, we conducted a cross-sectional survey among adult (ages 18–45) online panelists in the US (n = 1128) and Israel (n = 1094), oversampling tobacco users, in the fall of 2021, and used multivariable regression to identify correlates of (1) ever using IQOS; (2) past-month vs. former among ever users; and (3) interest in trying IQOS among never users. Among US adults, correlates of ever use included being Asian (aOR = 3.30) or Hispanic (aOR = 2.83) vs. White, and past-month use of cigarettes (aOR = 3.32), e-cigarettes (aOR = 2.67), and other tobacco (aOR = 3.34); in Israel, correlates included being younger (aOR = 0.97), male (aOR = 1.64), and cigarette (aOR = 4.01), e-cigarette (aOR = 1.92) and other tobacco use (aOR = 1.63). Among never users, correlates of greater interest included cigarette and e-cigarette use in the US (β = 0.57, β = 0.90) and Israel (β = 0.88, β = 0.92). IQOS use prevalence was low (US: 3.0%; Israel: 16.2%) but represented in vulnerable subpopulations (younger adults, racial/ethnic minorities).",

keywords = "alternative tobacco products, global health, heated tobacco products, non-cigarette tobacco products, tobacco control, tobacco use",

author = "Hagai Levine and Zongshuan Duan and Yael Bar-Zeev and Abroms, {Lorien C.} and Amal Khayat and Sararat Tosakoon and Romm, {Katelyn F.} and Yan Wang and Berg, {Carla J.}",

note = "Funding Information: This research was funded by the US National Cancer Institute (R01CA239178-01A1, MPIs: Berg, Levine). Berg is also supported by other US National Institutes of Health funding, including the National Cancer Institute (R01CA215155-01A1; PI: Berg; R21CA261884-01A1, MPIs: Berg, Arem), the Fogarty International Center (R01TW010664-01, MPIs: Berg, Kegler), the National Institute of Environmental Health Sciences/Fogarty (D43ES030927-01, MPIs: Berg, Caudle, Sturua), and the National Institute on Drug Abuse (R01DA054751-01A1, MPIs: Berg, Cavazos-Rehg). Romm is supported by the National Institute on Drug Abuse (R25DA054015, MPIs: Obasi, Reitzel), the Oklahoma Tobacco Settlement Endowment Trust (TSET) contract #R22-03, and the National Cancer Institute grant awarded to the Stephenson Cancer Center (P30CA225520). Publisher Copyright: {\textcopyright} 2023 by the authors.",

year = "2023",

month = feb,

doi = "10.3390/ijerph20043141",

language = "American English",

volume = "20",

journal = "International Journal of Environmental Research and Public Health",

issn = "1661-7827",

publisher = "MDPI Multidisciplinary Digital Publishing Institute",

number = "4",

}

TY - JOUR

T1 - IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel

AU - Levine, Hagai

AU - Duan, Zongshuan

AU - Bar-Zeev, Yael

AU - Abroms, Lorien C.

AU - Khayat, Amal

AU - Tosakoon, Sararat

AU - Romm, Katelyn F.

AU - Wang, Yan

AU - Berg, Carla J.

N1 - Funding Information: This research was funded by the US National Cancer Institute (R01CA239178-01A1, MPIs: Berg, Levine). Berg is also supported by other US National Institutes of Health funding, including the National Cancer Institute (R01CA215155-01A1; PI: Berg; R21CA261884-01A1, MPIs: Berg, Arem), the Fogarty International Center (R01TW010664-01, MPIs: Berg, Kegler), the National Institute of Environmental Health Sciences/Fogarty (D43ES030927-01, MPIs: Berg, Caudle, Sturua), and the National Institute on Drug Abuse (R01DA054751-01A1, MPIs: Berg, Cavazos-Rehg). Romm is supported by the National Institute on Drug Abuse (R25DA054015, MPIs: Obasi, Reitzel), the Oklahoma Tobacco Settlement Endowment Trust (TSET) contract #R22-03, and the National Cancer Institute grant awarded to the Stephenson Cancer Center (P30CA225520). Publisher Copyright: © 2023 by the authors.

PY - 2023/2

Y1 - 2023/2

N2 - Heated tobacco products (HTPs) have expanded globally. IQOS, a global HTP leader, was launched in Israel in 2016 and the US in 2019. To inform tobacco control efforts, it is critical to understand who is likely to use HTPs in different countries with distinct regulatory and marketing contexts. Thus, we conducted a cross-sectional survey among adult (ages 18–45) online panelists in the US (n = 1128) and Israel (n = 1094), oversampling tobacco users, in the fall of 2021, and used multivariable regression to identify correlates of (1) ever using IQOS; (2) past-month vs. former among ever users; and (3) interest in trying IQOS among never users. Among US adults, correlates of ever use included being Asian (aOR = 3.30) or Hispanic (aOR = 2.83) vs. White, and past-month use of cigarettes (aOR = 3.32), e-cigarettes (aOR = 2.67), and other tobacco (aOR = 3.34); in Israel, correlates included being younger (aOR = 0.97), male (aOR = 1.64), and cigarette (aOR = 4.01), e-cigarette (aOR = 1.92) and other tobacco use (aOR = 1.63). Among never users, correlates of greater interest included cigarette and e-cigarette use in the US (β = 0.57, β = 0.90) and Israel (β = 0.88, β = 0.92). IQOS use prevalence was low (US: 3.0%; Israel: 16.2%) but represented in vulnerable subpopulations (younger adults, racial/ethnic minorities).

AB - Heated tobacco products (HTPs) have expanded globally. IQOS, a global HTP leader, was launched in Israel in 2016 and the US in 2019. To inform tobacco control efforts, it is critical to understand who is likely to use HTPs in different countries with distinct regulatory and marketing contexts. Thus, we conducted a cross-sectional survey among adult (ages 18–45) online panelists in the US (n = 1128) and Israel (n = 1094), oversampling tobacco users, in the fall of 2021, and used multivariable regression to identify correlates of (1) ever using IQOS; (2) past-month vs. former among ever users; and (3) interest in trying IQOS among never users. Among US adults, correlates of ever use included being Asian (aOR = 3.30) or Hispanic (aOR = 2.83) vs. White, and past-month use of cigarettes (aOR = 3.32), e-cigarettes (aOR = 2.67), and other tobacco (aOR = 3.34); in Israel, correlates included being younger (aOR = 0.97), male (aOR = 1.64), and cigarette (aOR = 4.01), e-cigarette (aOR = 1.92) and other tobacco use (aOR = 1.63). Among never users, correlates of greater interest included cigarette and e-cigarette use in the US (β = 0.57, β = 0.90) and Israel (β = 0.88, β = 0.92). IQOS use prevalence was low (US: 3.0%; Israel: 16.2%) but represented in vulnerable subpopulations (younger adults, racial/ethnic minorities).

KW - alternative tobacco products

KW - global health

KW - heated tobacco products

KW - non-cigarette tobacco products

KW - tobacco control

KW - tobacco use

UR - http://www.scopus.com/inward/record.url?scp=85148963900&partnerID=8YFLogxK

U2 - 10.3390/ijerph20043141

DO - 10.3390/ijerph20043141

M3 - Article

C2 - 36833831

AN - SCOPUS:85148963900

SN - 1661-7827

VL - 20

JO - International Journal of Environmental Research and Public Health

JF - International Journal of Environmental Research and Public Health

IS - 4

M1 - 3141

ER -

IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this